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Objectives. The aim of the present paper was to review the published literature in order to identify all relevant studies for inclusion
and to determine whether there was any evidence of the efficacy of strontium and potassium toothpastes in the treatment of dentine
hypersensitivity (DH). Methods. Following a review of 94 relevant papers both from searching electronic databases (PUBMED)
and hand searching of relevant written journals, 13 studies were identified, and 7 papers (1 for strontium-based toothpastes and
6 for potassium-based toothpastes) were finally accepted for inclusion. The main outcome measures were the methodology and
assessment used by Investigators in studies designed to evaluate DH. Results. The results of the present paper would indicate that
the reported efficacy of both strontium- and potassium-based toothpastes in relieving DH is questionable. Conclusions. The results
from the present paper would appear to support the conclusions of previous investigators that there is only minimal evidence for
the efficacy of both strontium- and potassium-based toothpastes in relieving symptoms of DH.
1. Introduction
Dentine hypersensitivity (DH) is a relatively common dental
condition which may have a profound effect on the quality of
life of thosewho sufferwith the problem.Themain presenting
symptom is pain generally in response to cold stimuli. It
is also evident from the published literature that DH may
be underreported by dental professionals who may have
problems in the diagnosis and management of the condition
[1, 2]. There are a number of products that have been
formulated for either in-office or over-the-counter (OTC)
applications, and the mechanism of action of these products
appears to work (as evaluated in laboratory-based studies)
either on the basis of their tubular occluding properties,
for example, restoratives materials such as resins, varnishes,
and toothpastes, or by nerve desensitization, for example,
potassium-based (chloride, citrate, and nitrate) products [3].
Generally speaking the application of an in-office product
may be limited to patients with severe DH limited to
one or two affected teeth whereas the recommendation of
an OTC product such as a toothpaste or mouthwash may be
suitable for patients or consumers with generalized mild to
moderate DH [3]. One of the problems when evaluating the
efficacy or perceived success of these products is that pain
is very subjective and the pain experience may vary from
individual to individual [4]. The evaluation of these products
is generally conducted by dental professionals in a clinical
study that would determine the efficacy or effectiveness of
a desensitizing product compared to a placebo, negative, or
positive control [5]. The duration of these studies would be
determined to some extent as to whether the product was
an in-office or OTC product and the clinical claims to be
made, for example, instant relief fromDHand/or long-lasting
relief [5, 6]. There are a number of problems associated with
these studies, for example, the variation of the methodology
employed and whether they are typical of the stimuli or
sensation experienced by patients and consumers in day-to-
day experience [4]. A further concern from these studies may
be related to whether the study population is truly repre-
sentative of the individual suffering from DH in the general
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community. Although there is evidence from the published
literature that these products have demonstrated measurable
positive improvements in terms of percentage reductions
from baseline values, it is difficult to determine the clinical
relevance of such reductions in individuals with DH [5, 7–9].
Ideally a true end-point or clinical outcome from these stud-
ies would be the complete absence of discomfort following
the application of a product in the in-office situation or relief
of discomfort over time when using an OTC product that
may enable an individual to have an accepted quality of life
without the previously perceived discomfort [4, 5]. Currently
no universally acceptedOTCproduct that completely relieves
the symptoms of DH appears to be available although there
are a number of products that have been formulated for the
treatment and management of DH which have demonstrated
varying degrees of effectiveness. For example, products that
have been shown to act as tubular occludents, such as
strontium-based toothpastes, Pro-Argin-based toothpastes
containing arginine and calcium carbonate, hydroxyapatite
and NovaMin (calcium sodium phosphosilicate) toothpastes
or products that act as a nerve desensitiser (e.g., potassium-
based products) [3, 10–12]. The aim of the present paper was
therefore to identify all relevant studies from the available
published literature in order to determine whether there was
any evidence of the efficacy of a tubular occludent (strontium)
and a nerve desensitiser (potassium) toothpaste for the
treatment of DH.The objective was also to update the results
from previous reviews for potassium-based toothpastes [7–
10] and strontium-based toothpastes [11], respectively, in the
published literature up to 31st December 2010 using an agreed
search protocol based on a modified version of Poulsen et al.
[9] and Hsui [13].
2. Aim and Objectives
The aim of this paper was to examine the available published
literature in order to determine the efficacy of both strontium
(Sr) (chloride and acetate) and potassium (K+) (nitrate,
citrate, and chloride) toothpastes in the treatment of DH.
3. Methodology
The searchmethodology used for the present study was based
on a modified version of Poulsen et al. [9] and Hsui [13] as
indicated later.
3.1. Selection Criteria
3.1.1. Types of Study. This review included any type of studies
(e.g., randomized controlled clinical trials) in which stron-
tium and/or potassium-containing toothpastes/gels were
compared to nonpotassium and/or nonstrontium tooth-
pastes.
3.1.2. Types of Participants. Included criteria for the relevant
studies were dentate, healthy human adults (at least 18 years of
age) with a known history of DH from exposed root dentine
surfaces.
3.1.3. Types of Interventions. This includes the daily home use
of strontium and/or potassium-containing toothpastes/gels
compared to control toothpastes/gels. In each study the
toothpastes compared will either both contain fluoride or
have no fluoride.The control toothpaste was exactly the same
as the test toothpaste apart from the addition of either a
strontium or potassium salt.
3.1.4. Types of Outcome Measures. This includes changes
in (1) pain symptoms in response to the test procedures,
including tactile, thermal, and air blast stimuli, or (2) patients’
subjective assessment of pain during their daily experience.
Only studies that reported data after 6 and 8 weeks were
included in the review.
4. Search Strategy
The search strategy included using hand searching or elec-
tronic databases (e.g., PUBMED) up to 31st December 2010.
The hand searching process also included examining relevant
published or incomplete journals in English. The searching
key words in PUBMED were (cervical OR tooth OR teeth
OR dentin∗ OR dental) AND (sensitiv∗ OR hypersensitiv∗
OR pain∗) AND (Efficacy∗) AND (random∗ OR trial OR
(randomized controlled trial [pt]) OR (controlled clinical
trial [pt]) OR cohort∗ OR longitudinal∗ OR “follow up” OR
prospective∗ OR case-control).
5. Statistical Analysis
Statistical analysis of data from these studies was not
attempted due to the variations in the study design, method-
ology, study duration, and reporting of the pain response
(percentages, VAS scores, or pain categories, etc.).
6. Method of the Review (Data Collection
and Analysis)
From the titles retrieved in the electronic search all relevant
clinical studies and reviews were identified by one of the
authors (Belkais Karim [BK]) who then obtained copies of all
the relevant studies where available for further consideration.
Two reviewers (BK and David Gillam [DG]) determined
the quality of the eligible papers and data extraction based
on the randomisation procedure, allocation concealment,
blinding, and description of any dropouts (withdrawals) [13,
14]. Any differences as to inclusion or exclusion of articles
were resolved following discussion between BK and DG.
Data extracted from the included and excluded studies was
completed on the relevant data extraction forms [13].
Sensitivity from DH was assessed using the following
types of measurements: tactile (pressure with a standardised
probe) or thermal (heat/cold) stimulation or evaporative
(air blast) stimulation. Patients’ subjective assessment was
also included in the analysis. Only sensitivity measurements
recorded after 6 and 8 weeks were included due to the
variability in the length of the published studies.
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7. Results
7.1. Overall Description of the Included and Excluded Studies.
After the initial screening of identified articles for the present
paper, there were 390 potentially relevant studies found either
by searching the electronic databases (PUBMED) or by hand
searching articles from the literature. Unpublished articles
were found both by searching the electronic databases and by
hand searching. 94 studies were regarded as relevant for this
study while 296 studies were excluded (Figure 1). Following
an evaluation of the selected 94 studies, 87 studies were
excluded, 32 of these studieswere strontium-based toothpaste
studies [7, 15–45] (Table 1), and 55 were potassium-based
toothpaste studies [3, 9, 46–98] (Table 2). The reasons for
exclusion of these 87 studies are detailed in Tables 1 and 2.
7 strontium- and potassium-based toothpaste studies were
included in the present paper [99–105] (Tables 3 and 4).
The flow diagram (Figure 1) of the selection procedure is
illustrated later.
7 strontium- and potassium-based toothpaste studies
therefore fulfilled the criteria for inclusion in the review. In
all these studies the experimental toothpaste either contained
strontium or potassium whereas the control toothpastes
were without strontium or potassium. From the 7 included
studies, only 1 article was identified specifically for strontium
salts (as the principal (test) toothpaste) and 6 articles were
identified specifically for potassium salts (as the principal
(test) toothpaste). The description of the 7 included studies
is shown in Tables 3 and 4.
7.2. Analysis of Included Studies
7.2.1. Study Design. The 7 studies included in the present
paper were only from randomised controlled parallel groups
blind clinical Trials (RCT). The control toothpastes were
either positive (active) [101–103, 105] or negative (placebo)
[99, 100, 104]. The blindness was double-blinded [99–105].
7.2.2. Study Population. Most included studies were con-
ducted in either dental practices or university hospitals. The
recruited study participants in the included studies were
dentate, healthy human adults with a known history of DH.
Regarding the gender distribution, most of the included
studies enrolled mainly females [99–105]. The total numbers
of participants (447) from the 7 included studies were as
follows: (1) for the one strontium-based study there were 57
participants and (2) for the six potassium-based studies there
were 390 participants, respectively (Tables 3 and 4).
7.2.3. Age Range of Participants. There was variation in the
age range distribution(s) in the included studies; however all
participants in the included studies were adults (at least 18
years of age). All 7 included studies reported both the age
range and the mean age.
7.2.4. Study Duration. The duration of the 7 included studies
evaluating the efficacy of strontium- and potassium-based
toothpastes/gels in DH was short term (no longer than
Screening potentially relevant articles by
electronic databases and hand searching: 389
studies were found
296 articles rejected
94 articles included
87 articles rejected
Initial screening
2nd screening
7 articles included
(Sr1 + k
+
6)
Figure 1: Flow diagram of the study selection process.
3 months), ranging from 8 to 12 weeks (Table 5). According
to the Poulsen et al. [9] systematic review, only studies that
reported sensitivity measurements following 6 and 8 weeks
of product use were included in their 2008 review.
7.2.5. Statistics Power Calculation. There were a wide variety
of statistical tests used in the included studies. The most
commonly used test was “ANOVA” [99, 101–104] (Table 6).
7.2.6. Randomisation and Allocation Concealment (See [13]).
According to Schulz [107] random allocation to interven-
tion groups in a clinical study remains the only method
of ensuring that the groups being compared are on an
equivalent footing at study outset, thus eliminating selection
and confounding biases. In most of the 7 included studies
the degree of concealment was unclear (random alloca-
tion stated/indicated but the actual allocation concealment
method is not described or an apparently adequate conceal-
ment scheme is reported but there is uncertainty whether
allocation is adequately concealed) [100–105]. In the Minkoff
and Axelrod [99] strontium study the randomization process
was made externally by a statistical department using a
computer-generated random table.
7.2.7. Consideration of Withdrawals and Dropouts (See
[13]). According to Bowers [108, 109] withdrawals and
dropouts that occur following the randomization process
may adversely affect the balance of the two groups that had
been achieved through the randomization process whichmay
in turn affect any subsequent data analysis (through loss of
data). One way of resolving this problem is to include data
of these participants as they were still in the study; this is
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Table 1: Characteristics of Strontium-based toothpastes excluded studies (reasons).
No. Study Reason for exclusion
1 Addy et al. [15] Different abrasive concentrations and compounds in the test and comparison toothpastes
2 Blitzer [16] The selected participants had developed a general sensitivity during the course of periodontal treatment
3 Carrasco [17] Study duration was only 20 days (∼3 weeks)
4 Dabsie et al. [18] In vitro study
5 Earl et al. [19] In vitro study
6 Gedalia et al. [20] In vitro study
7 Gedalia et al. [21] The use of SrCl2 solution
8 Gillam et al. [22] Study reported on the effect of SrCl2 toothpaste on plaque accumulation and gingival inflammation
9 Gillam et al. [23] Study reported on the effect of different toothpaste abrasive DH
10 ∗Goldie [24] Review (2011)
11 Gutentag [25] In vitro study
12 Hughes et al. [26] Different fluoride concentrations and compounds in the test and comparison toothpastes
13 ∗Jackson [7] Review
14 ∗Kanapka [27] Review
15 ∗Kishore et al. [28] Not clear if the study was randomised
16 Kobler et al. [29] SrCl2 solution (varnish) was used
17 ∗Markowitz [30] Review
18 Mason et al. [31] Different fluoride concentration in the test and comparison toothpastes
19 Parkinson et al. [32] In vitro study
20 Pearce et al. [33] Different fluoride concentrations and compounds in the test and comparison toothpastes
21 ∗Pol et al. [34] Unobtainable article (review?)
22 Ross [35] No control (placebo/active) group
23 Shapiro et al. [36] Abstract only
24 Shapiro et al. [37] The outcome measurements were not clear
25 Stazen and Forman [38] In vitro study
26 Surdacka et al. [39] In vitro study
27 ∗Tarbet et al. [40] Study duration was only 4 weeks
28 Uchida et al. [41] Study on the efficacy of SrCl2 in the management of DH following periodontal surgery
29 ∗West [42] Different fluoride concentrations and compounds in the test and comparison toothpastes
30 West et al. [43] Abstract
31 Collins and Perkins [44] Different compounds in the test and comparison toothpastes. No strontium-free placebo
32 Kumar et al. [45] Different compounds in the test and comparison toothpastes. No strontium-free placebo
∗Studies contain both Strontium and Potassium together.
called intention-to-treat analysis. Withdrawals and dropouts
were reported in 4 out of 7 included studies (Table 7).
8. Data Analysis
No further analyses were performed on the mean differences
from 6 to 8 weeks for any other measurement outcomes for
the purpose of meta-analysis.
8.1. Previous History of DH Reported at Baseline. This entails
any history of DH in the included studies, reported by inves-
tigators, in the form of baseline data, which was confirmed by
a response to tactile and/or thermal stimulus.
8.2. Types of Treatment Intervention. In all the 7 included
studies a daily homeuse of strontium- [99] and/or potassium-
[100–105] based toothpastes/gels versus controls (strontium-
or potassium-free toothpastes) was the only type of treatment
intervention.
8.3. The Clinical Methodology Used to Assess DH. The most
commonly reported DH/RS assessment methods by inves-
tigators in the 7 included studies were tactile (mainly by
using a Yeaple probe), thermal (hot/cold air or water), and
evaporative (air blast). Tables 3 and 4 show a summary
of the characteristics of the included studies including the
assessment methods used for DH. Regarding the subjective
assessment of DH, VAS was the main subjective scale used
[101, 104]. The Nagata et al. study [100] used Tarbet’s four-
point air sensitivity scale [78, 106]. Only three included
studies used the Schiff ’s cold air sensitivity scale [102, 103,
105]. However, two studies used questionnaires [99, 100]
(Table 8).
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Table 2: Characteristics of potassium based toothpastes excluded studies (reasons).
No. Study Reason for exclusion
1 Ajcharanukul et al. [46] KCl solution was used
2 Andreana et al. [47] Abstract only
3 Aris et al. [48] Abstract only
4 Ayad et al. [49] Different fluoride concentrations and compounds in the test and comparisontoothpastes
5 Ayad et al. [50] Different fluoride concentrations and compounds in the test and comparisontoothpastes
6 Bohen and Lafont [51] In-office treatment
7 Browning et al. [52] Study on the safety and efficacy of a night guard bleaching agent containingNaF and KNO3
8 Charig et al. [53] Abstract only
9 Conforti et al. [54]
Study duration: 14 days (2 weeks)
Different fluoride concentrations and compounds in the test and comparison
toothpastes
10 Cooley and Sandoval [55] Potassium oxalate solution was used
11 Docimo et al. [56] Different fluoride concentrations and compounds in the test and comparisontoothpastes
12 Frechoso et al. [57] Study duration was 14 days (2 weeks)
13 Gillam et al. [58] KNO3 mouthwash was used
14 Gillam et al. [59] Different fluoride concentrations and compounds in the test and comparisontoothpastes
15 Goncalves et al. [60] Abstract only
16 Hall et al. [61] Abstract only
17 Van Haywood et al. [62] Study on the efficacy of KNO3—F gel to reduce bleaching sensitivity
18 Haywood et al. [63] Study on the efficacy of KNO3 toothpaste to reduce bleaching sensitivity
19 Hodosh [64] Review
20 Hodosh [65] Not an RCT
21 Jalalian et al. [66] Study on the efficacy of KNO3 in reduction of hypersensitivity in teeth withfull-crown preparations
22 Kawamata et al. [67] Abstract only
23 Lecointre et al. [68] Different fluoride concentrations and compounds in the test and comparisontoothpastes. Study duration: 4 weeks
24 Manochehr-pour et al. [69] Incomplete data
25 McCormack and Davies. [70] Review
26 Mordan et al. [71] Abstract only
27 Morris et al. [72] Abstract only
28 Orchardson and Gillam [3] Review
29 Pamir et al. [73] In-office treatment
30 Peacock and Orchardson [74] Animal (rat) study for the effect of (K) ions on action potential conduction inA- and C-fibres
31 Peacock and Orchardson [75] Animal (rat) study to assess the ability of some organic (K) salts to blockaction potential conduction
32 Pereira et al. [76] In vitro study
33 Pillon et al. [77] Study on the effect of a single application of 3% potassium oxalate gelimmediately after subgingival scaling and root planning on DH
34 Pol et al. [78] Review
35 Poulsen et al. [9] Review
36 Prasad et al. [79] Different fluoride concentrations and compounds in the test and comparisontoothpastes
37 Reinhart et al. [80] A pilot study
38 Salian et al. [81] Study duration: 4 weeks
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Table 2: Continued.
No. Study Reason for exclusion
39 Salvato et al. [82] Different fluoride concentrations and compounds in the test and comparisontoothpastes
40 Sharma [83]∗ No data available at 6 to 8 weeks
41 Sharma et al. [84] No data available at 6 to 8 weeks
42 Silverman [85] Test and control toothpastes were not clearly detailed
43 Silverman et al. [86] Incomplete data
44 Sowinski et al. [87] No potassium-free comparison group; different fluoride concentrations andcompounds in the test and comparison groups
45 Sowinski et al. [88] Different fluoride concentrations and compounds in the test and comparisontoothpastes
46 Stead et al. [89] Review (mathematical model)
47 Tarbet et al. [90] Not clear if the study was randomized. Study duration: 4 weeks
48 Tarbet et al. [91] Study on the pulpal effects of brushing with a (5% KNO3) paste used fordesensitization
49 Touyz and Stern [92] KNO3 solution was used to reduce DH after periodontal surgery
50 Wang et al. [93] Abstract only
51 Wara-aswapati et al. [94] No data available at 6 to 8 weeks
52 Yates et al. [95] Potassium citrate-containing mouth rinse was used
53 Yates et al. [96] No potassium-free comparison group
54 Orsini et al. [97] Different fluoride concentrations and compounds in the test and comparisontoothpastes
55 Pradeep and Sharma [98]
Different compounds in the test and comparison toothpastes. Calcium
sodium phosphosilicate was evaluated against a potassium nitrate and placebo
with no calcium sodium phosphosilicate
∗http://www.oralscience.ca/. A randomized parallel group clinical study accessed 2010.
Table 3: Characteristics of the included Strontium containing toothpaste studies.
No. Study Methods Participants Interventions Outcomes Results
1
Minkoff and
Axelrod
[99]∗
12 weeks, parallel,
double-blind,
randomised
57 completing
out of 61
10% SrCl2
versus 0% SrCl2
Tactile and
thermal
SrCl2 > placebo control (P < 0.05) after 4 weeks
(subjective), after 8 weeks (air blast), and at 12 weeks
(tactile)
∗Formulation was subsequently changed from an SrCl2 with diatomaceous earth to SrCl2 with a silica abrasive/filler. A Strontium chloride toothpaste is no
longer available in some markets. A Strontium acetate with fluoride toothpaste is currently available.
8.4. Calibration and Examiner Training. Therewas no report-
ed training or calibration for DH, in either the examination
or assessment techniques prior to the commencement of the
study, in any of the included studies.
8.5. Measurement of Compliance. There was no reported
measurement of patient compliance, for example, diaries,
weighing of toothpastes, or log books in any of the included
studies.
9. Discussion
It is evident from the published literature that DH is not only
a troublesome condition for dental professionals to effectively
diagnose and manage but it may also have a profound effect
on the quality of life of those who suffer with the problem
[110–112]. Currently there is a plethora of remedies available
for both OTC and in-office applications; however it is evident
that none of these products appear to provide an effective
long-lasting solution to the problem [1, 3]. Most of these
products either work on the basis of their tubular occlud-
ing properties, for example, strontium-based (chloride and
acetate) products, or by nerve desensitization, for example,
potassium-based (chloride, citrate, and nitrate) products.
Evidence for their efficacy however has been questioned by
several investigators in a series of reviews over the last decade
[7–11, 113].
The aim of the present paper was to evaluate the efficacy
of both strontium and potassium toothpastes based on the
published systematic review methodology of Poulsen et al.
[9]; however the authors concede that the present paper may
have been too restrictive in considering only studies with
matched placebo controls. It may therefore be argued that
the inclusion of studies with a valid negative control, such
as a commercially available fluoride toothpaste, may have
given a better indication of whether a toothpaste containing
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Table 4: Characteristics of Potassium containing toothpastes included studies.
No. Study Methods Participants Interventions Outcomes Results
1 Nagata et al.[100]
12 weeks, parallel,
double-blind,
randomised
36 completing
out of 36 5% KNO3 versus 0% KNO3
Tactile, air blast,
and subjective
5% KNO3 > control (P,
0.05) at 4, 8, and 12 weeks
2 Schiff et al.[101]
12 weeks, parallel,
double-blind,
randomised
58 completing
out of 67
5% KNO3 and 0.243%
sodiumMFP versus 0%
KNO3 and 0.243% sodium
MFP
Thermal, tactile, air
blast, and
subjective
Test > control (P < 0.01) at
6 and 12 weeks
3 Schiff et al.[102]
8 weeks, parallel,
double-blind,
randomised
39 completing
out of 48
5% KNO3 and 1500 ppm
MFP versus 0% KNO3 and
1500 ppmMFP
Tactile and air blast 5% KNO3 > control (P <0.0001) at 4 and 8 weeks
4 Schiff et al.[103]
8 weeks, parallel,
double-blind,
randomised
80 participants 5% KNO3 and 0.243% NaFversus 0.243% NaF Tactile and air blast
5% KNO3 > positive and
negative controls (P < 0.05)
in tactile and air blast
sensitivity, at 4 and 8 weeks
5 Silverman et al.[104]
8 weeks, parallel,
double-blind,
randomised
110 completing 5% KNO3 versus 0% KNO3
Tactile, cold air,
and subjective
5% KNO3 > +/− F > F
control at 4 and 8 weeks (P
< 0.02); NS between 10% Sr
Cl2 and control; 5% KNO3
> +/− F > 10% Sr Cl2 at 8
weeks (P < 0.05)
6 Sowinski et al.[105]∗
8 weeks, parallel,
double-blind,
randomised
67 completing 5% KNO3 and 0.243% NaFversus 0.243% NaF Tactile and air blast
KNO3 > control significant
improvements in tactile and
air blast at 4 and 8 weeks
∗Product withdrawn from the market.
Table 5: Study duration of included studies.
Study Study duration
Minkoff and Axelrod [99] 12 weeks
Nagata et al. [100] 12 weeks
Schiff et al. [101] 12 weeks
Pradeep and Sharma [98] 8 weeks
Schiff et al. [102] 8 weeks
Schiff et al. [103] 8 weeks
Sowinski et al. [105] 8 weeks
Table 6: Statistical tests used in the included studies.
Study Statistical test
Minkoff and Axelrod [99] ANOVA, t-test, Spearman’s rankcorrelation coefficient
Nagata et al. [100]
Mann-Whitney U test
Chi-square/Fisher’s exact probability
test
Schiff et al. [101–103] ANOVAt-test
Silverman et al. [104] ANOVA
Sowinski et al. [105] t-test
the active ingredient could deliver the desired efficacy (e.g., a
reduction in sensitivity). The rationale however for conduct-
ing the present paper was to determine whether the active
ingredient in toothpaste delivers efficacy in the reduction
of DH which is the basis of the claims made for these
toothpastes by the manufacturers. Other benefits that have
been attributed to these toothpastes such as antiplaque and
anticaries benefits have not been considered in the present
paper. Generally speaking these benefits are often “based on
the results of previous caries studies or plaque studies and
there is very little evidence from the published literature on
desensitising toothpastes that these ingredients have been
shown to demonstrate these benefits” [22, 23, 65].
For the purpose of the present paper, studies (e.g.,
randomized controlled clinical trials) were included in which
strontium and/or potassium-containing toothpastes/gels
were compared to nonpotassium and/or nonstrontium
toothpastes. The type of intervention examined was the
daily home use of strontium and/or potassium-containing
toothpastes/gels versus control toothpastes/gels. In each
study the toothpastes were either both containing fluoride
or having no fluoride and the control toothpaste was exactly
the same as the test toothpaste apart from the addition of
either a strontium (acetate or chloride) or potassium (citrate,
chloride, and citrate) salt. It should be noted that currently
most strontium-based toothpastes contain an acetate variant
rather than the chloride variant and potassium-based
toothpastes contain a nitrate variant depending on the
particular commercial market.
Following an initial screening of the available publica-
tions there were a total of 87 excluded studies following the
final filtration of 94 studies (Tables 1 and 2 and Figure 1).
The reasons for excluding 32 strontium studies were either
due to the different fluoride or abrasive concentrations and
compounds in both test and comparison toothpastes [26,
31, 33, 42, 114]. Two studies were excluded as they were
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Table 7: Number of dropout participants from the included studies and the reasons for dropout (4 studies).
Study No. of dropouts Reason(s) for dropping out
Minkoff and Axelrod [99] 4 out of 61 3 had minor side effects upon use of active product1 for personal reasons
Schiff et al. [101] 9 out of 67 For reasons unrelated to dentifrice use
Schiff et al. [102] 9 out of 48 For reasons unrelated to dentifrice use
Sowinski et al. [105] All participants completed No dropouts recorded
Table 8: The different types of DH assessment used in the included studies.
Study DH assessment method(s) Subjective assessment
Minkoff and Axelrod [99] Tactile and thermal Questionnaire
Nagata et al. [100] Tactile and air blast Tarbet’s scale and questionnaire [106]
Schiff et al. [101] Tactile, air blast, and thermodontic stimulator (thermal) VAS
Schiff et al. [102, 103] Tactile and air blast Schiff ’s sensitivity scale (0–3)
Silverman et al. [104] Tactile and air blast VAS
Sowinski et al. [105] Tactile and air blast Schiff ’s sensitivity scale (0–3)
related to DH following periodontal treatment (nonsurgical
or surgical studies) [16, 41]. A further two studies were
excluded due to the short study duration <6 weeks [17, 40]. A
further seven studies were also excluded as they were in vitro
studies [18–20, 25, 32, 38, 39]. Two studies were also excluded
since only Sr Cl
2
solutions/varnishes were used [21, 29]. The
Gillam et al. 1992 studies [22, 23] were also excluded as these
investigators reported on (1) the effects of Sr Cl
2
toothpaste
on plaque accumulation and/or gingival recession and (2) the
effect of different toothpaste abrasives in the test and control
toothpastes. One study by Shapiro et al. [36] was excluded
as it was a reported abstract article and a further study by
Shapiro et al. [37] was also excluded due to the lack of clarity
in the reported outcome measures. Two further studies were
also excluded due to (1) the lack of randomisation procedures
[28] and (2) the lack of a control group [35]. Several review
articles were also excluded [7, 24, 27]. Two further studies
by Collins and Perkins [44] and Kumar et al. [45] were
subsequently excluded by one of the authors (DGG) after the
initial filtration of included studies as it was apparent that
there were different compounds in the test and comparison
toothpastes and no strontium-free control. In summary, 32
strontium-related studies were excluded (Table 1) and only 1
studywas included in the present paper (Table 3).The reasons
for the exclusion of the 55 potassium-based toothpaste studies
were mainly due to the different fluoride concentrations
and/or ingredient(s) in the test and comparison toothpastes
[49, 50, 54, 56, 68, 79, 82, 88, 97] (Table 2). For example,
three studies were excluded since the main aim of these
studies was to evaluate the efficacy of KNO
3
toothpaste/gel
in reducing bleaching sensitivity during or following tooth
whitening/bleaching procedures [52, 62, 63]. Five studies
were also excluded due to the short study duration of the
study (<6 weeks) [54, 57, 68, 81, 90]. A further three studies
were excluded as these studies were either in-office [51, 73]
or in vitro studies [76]. Five studies were also excluded as
potassium-containing solutions/mouthwasheswere used [46,
55, 58, 92, 95]. The Jalalian et al. [66] study was also excluded
since this was a study evaluating the efficacy of an KNO
3
application in reducing DH with full-crown preparations.
The study by Pillon et al. [77] was also excluded since the
study was based on the results of a single application of
3% potassium oxalate gel immediately following scaling and
root planning procedures (SRP). The Tarbet et al. [91] study
was also excluded as this study only evaluated the pulpal
effect following brushing with a 5% KNO
3
toothpaste. A
further nine studies were excluded since these studies were
reported in an abstract [47, 48, 53, 60, 61, 67, 71, 72, 93].
A review by Hodosh [64] was also excluded as well as a
non-RCT study reported by the same investigator [65]. A
study byManochehr-Pour et al. [69] was also excluded due to
incomplete data reported in the study.The two animal studies
by Peacock and Orchardson [74, 75] were also excluded and a
pilot study reported by Reinhart et al. [80] was excluded.The
studies by Sharma [83], Sharma et al. [84], andWara-aswapati
et al. [94] were also excluded as no data was available at the 6-
to-8-week time intervals. Two studies by Silverman [85] and
Silverman et al. [86] were excluded either because (1) the test
and control toothpastes were not clearly detailed or (2) due
to incomplete data recorded in the study. In the Yates et al.
[96] study there was no potassium-free comparison group
included in the design of the study. The study by Stead et al.
[89] was excluded as this was a review paper. Other reviews,
by other investigators [24, 70, 78], were also excluded from
this paper. A further study by Pradeep and Sharma [98] was
subsequently excluded by one of the authors (DGG) as it
was apparent that there were different compounds in the test
and comparison toothpastes and no potassium-free control.
In this study a calcium sodium phosphosilicate toothpaste
was evaluated against a positive control potassium nitrate
and a placebo without calcium sodium phosphosilicate.
In summary, 55 potassium-based toothpaste studies were
excluded and the reasons for exclusion were described in
Table 2.
The results from the present paper were therefore
based on the 7 included studies (1 strontium-based and
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6 potassium-based toothpastes) and in context would appear
to support conclusions from the previous reviews that there
were measurable positive reductions in DH from baseline
values. Although the present review did not include meta-
analysis of the published data from these studies for the
reasons outlined earlier in the paper, the results from the
Poulsen et al. study [9] and the present paper were based on 6
potassium toothpaste studies.The results indicated that these
differences were in favour of the treatment group for both
“air” and “tactile” measurements but not for the “subjective”
measurements. Generally speaking interpreting air, tactile,
and subjective elements in DH studies is fraught with diffi-
culties [4, 115]. For example, most studies demonstrate that
the placebo group would provide significant improvements
in percentage terms as well as the test group and as such
any significance between the groups may be masked [7, 42].
The variation in the methodology employed by different
examiners (Table 8) may also have an impact on the efficacy
of a toothpaste as well as the highly subjective nature of the
pain response between individuals [9]. Some investigators
in the present paper used a Yeaple or an explorer probe
or a thermal probe versus a cold air blast or assessed the
subjective assessment using either a visual analogue scale
(VAS) or a Schiff scale [101–105] or questionnaires [99,
100, 106] (Tables 4 and 8). An observation when evaluating
the methodology reported in the included studies was that
there was no reporting of any training or calibration of
the investigators prior to the commencement of the studies.
Although a number of these investigators (e.g., Schiff [101–
103] were experienced assessors in DH evaluation studies it
was impossible to determine whether the investigators were
consistent in the assessments during the study. It should be
noted however that the variability of these subjective pain
outcomes is difficult to control even when using objective
measures [4].
One of the problems encountered when conducting the
present paper was that there was considerable variation with
the manner in the studies were designed and conducted, for
example, factors such as the duration, variation in sample
size, methodology used to assess the products as well as
differences in the test, placebo and control toothpastes and
the impact of the placebo and non-placebo improvements
in the control toothpastes, makes it difficult to make exact
comparisons from the results of these studies (Tables 3–
8) [7, 9, 11]. There is no doubt that there is a degree of
accommodation and awareness of the pain response by
individuals during a study as well as confounding variables
such as placebo and nonplacebo effects regression to the
mean or mode that may subsequently influence the study
outcomes. For example, Curro et al. [116] reporting on a series
of DH product evaluation studies indicated that there were a
number of false positives associated with tactile assessment
when using the Yeaple probe particularly at the lower range of
pressures. These investigators also highlighted that the range
of the placebo effect observed in DH studies is similar to that
observed in both medical and pharmaceutical studies.
One of the problems encountered when analysing data
from the published literature on the efficacy of strontium
and potassium-based toothpastes was that due to the strict
inclusion/exclusion criteria based on Poulsen et al. [9] in the
present paper none of the included studies made a direct
comparison between the two products (Tables 3 and 4). This
was a concern and the authors were therefore unable to com-
ment on a direct comparison between the twoproducts and as
such may limit the conclusions that could be made regarding
the two products. From the published literature it was evident
that earlier studies did provide direct comparisons of these
products although as Cummins [11] suggested in her review
that prior to 1997 there was considerably more variations
in the design and conduct of DH studies as well as the
ingredients of the toothpastes per se.This againmay confound
any meaningful conclusions when comparing results from
these DH evaluation studies. It should be noted however that
published studies (after 1997)would appear to follow a similar
design and conduct based on the Holland [5] and/or ADA
[6] guidelines when assessing various desensitising products.
Several investigators have however questioned the validity
and reproducibility of some of these techniques for evaluating
DH products [4, 115].
The results from the limited number of included
strontium-based studies in the present paper would therefore
limit any conclusions that may be drawn from the studies
(Table 3), even though there is some evidence of their
efficacy in a strontium chloride product [17, 21–23, 29, 41]
or a strontium acetate product [26, 31, 33, 42, 43, 59]. A
number of investigators have also reviewed the efficacy of
strontium-based toothpastes [7, 10, 30, 113]. Jackson [7]
however indicated in his review that none of the studies on
strontium toothpastes demonstrated a consistent, significant
improvement in the participants’ symptoms of DH when
compared with the negative control toothpaste. There also
appears to be no supportive evidence from the published
literature for strontium salts enhancing the deposition of the
ingredients of the toothpaste or increasing the durability of
the deposit on the tooth surface [7].
One of the aims of the present review was to update the
previous reviewof Poulsen et al. [9]; however no subsequently
published studies (up to 2010) were considered to be suitable
for inclusion and as a result no further information on the
efficacy of potassium-based toothpastes was forthcoming. A
number of investigators have also raised concernswith regard
to the efficacy of potassium-based toothpastes and this has
led to the suggestion that potassium-based toothpastes may
be no more effective than regular fluoride toothpaste [7, 8,
10]. The lack of data on the efficacy of potassium-containing
toothpastes in reducing DH has also been highlighted in a
recent systematic review by Pol et al. [78].
No conclusions however can be made from the present
paper on the direct comparison of the efficacy of strontium
and potassium-based toothpastes in reducing DH. This was
due to the limitation of any of the included studies making
a direct comparison between the two toothpastes although a
number of excluded studies did make such a comparison.
10. Conclusions
Although both strontium and potassium-based toothpastes
have been demonstrated to provide a reduction in clinical
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symptoms of DH in previously published clinical studies,
the conclusions from the present systematic review would
suggest that there is insufficient evidence to state categorically
whether strontium or potassium salts per se are effective in
reducing DH.
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